Saturday 17 October 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 14.6%, EPS grew 213.0%, free cash flow fell 43.9% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years.
268.62
6.51
−2.37%
Follow THC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 15.72 | 0.00 | 10.54 | 9.58 | 12.76 | 12.63 | 3.88 | 12.73 |
Piotroski F-Score |
5 | 3 | 6 | 5 | 6 | 7 | 4 | 9 | 7 | 7 |
P/S ratio |
0.08 | 0.08 | 0.10 | 0.21 | 0.24 | 0.45 | 0.27 | 0.38 | 0.59 | 0.84 |
Altman Z-Score |
0.96 | 0.94 | 1.01 | 1.01 | 0.98 | 1.28 | 1.14 | 1.29 | 2.00 | 1.91 |
Altman Z″-Score (non-manufacturers) |
0.48 | 0.36 | 0.43 | 0.36 | 0.83 | 1.11 | 0.95 | 1.26 | 2.75 | 2.29 |
P/FCF ratio |
0.00 | 3.26 | 4.05 | 6.98 | 1.46 | 9.59 | 16.32 | 4.76 | 10.96 | 7.08 |
Beneish M-Score |
(2.48) | (2.89) | (2.59) | (2.64) | (2.92) | (2.48) | (2.39) | (2.69) | (2.25) | (2.67) |
P/Operating CF |
(5.22) | 3.28 | 7.00 | 7.56 | 9.40 | 24.45 | 12.44 | 9.38 | (36.96) | 24.51 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 57 |
P/B ratio |
1.41 | 2.98 | 2.55 | 9.00 | 4.48 | 4.25 | 2.13 | 2.48 | 2.10 | 2.98 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.82 | 0.83 | 0.88 | 1.00 | 0.99 | 1.13 | 1.01 | 1.05 | 1.08 | 1.32 |
EV/EBITDA |
7.52 | 7.86 | 6.51 | 7.61 | 6.06 | 5.86 | 6.07 | 6.30 | 3.29 | 6.42 |
EV/Operating CF |
28.80 | 13.28 | 15.41 | 14.94 | 5.13 | 14.04 | 17.97 | 9.06 | 10.94 | 7.97 |
EV/FCF |
(50.69) | 32.32 | 37.42 | 32.72 | 6.09 | 24.19 | 60.62 | 13.25 | 20.06 | 11.15 |
Quick Ratio |
0.90 | 0.75 | 0.78 | 0.72 | 1.06 | 1.00 | 0.85 | 0.87 | 1.29 | 1.22 |
Current Ratio |
1.30 | 1.29 | 1.20 | 1.21 | 1.47 | 1.38 | 1.34 | 1.51 | 1.78 | 1.76 |
Net Debt/EBITDA |
6.80 | 7.07 | 5.80 | 5.98 | 4.60 | 3.53 | 4.43 | 4.04 | 1.49 | 2.34 |
Debt/Assets |
61.76% | 63.87% | 66.16% | 63.13% | 57.99% | 56.73% | 55.53% | 52.99% | 45.52% | 44.38% |
Debt/Equity |
14.10 | 27.71 | 21.58 | 33.76 | 16.78 | 7.62 | 6.13 | 4.81 | 2.26 | 2.19 |
Asset Turnover |
0.81 | 0.80 | 0.80 | 0.81 | 0.70 | 0.71 | 0.70 | 0.74 | 0.72 | 0.73 |
Operating CF/Net income |
(2.91) | (1.70) | 10.09 | (5.73) | 8.54 | 1.72 | 2.64 | 3.89 | 0.64 | 2.52 |
Capex/Depreciation |
(0.98) | (0.77) | (0.73) | (0.76) | (0.60) | (0.74) | (0.87) | (0.83) | (1.10) | (1.14) |
Interest Coverage |
1.27 | 1.08 | 1.63 | 1.56 | 1.98 | 3.11 | 2.62 | 2.79 | 7.21 | 4.27 |
| (18.82%) | (86.86%) | 16.97% | (38.26%) | 58.08% | 61.12% | 18.21% | 21.92% | 71.61% | 23.77% | |
| (0.79%) | (2.93%) | 0.45% | (0.94%) | 1.58% | 3.34% | 1.50% | 2.20% | 11.18% | 4.80% | |
ROIC |
4.99% | 4.68% | 6.77% | 6.44% | 8.75% | 11.70% | 8.74% | 9.29% | 23.30% | 13.45% |
Return on Tangible Assets |
(2.07%) | (8.51%) | 1.34% | (2.77%) | 4.44% | 10.89% | 5.16% | 7.07% | 33.97% | 14.50% |
Average Days of Receivables |
53.97 | 49.88 | 52.14 | 54.38 | 55.66 | 51.89 | 56.02 | 51.72 | 44.77 | 43.93 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.38 | 0.38 | 0.40 | 0.38 | 0.38 | 0.39 | 0.43 | 0.41 | 0.42 | 0.42 |
Share Based Compensation of Revenue |
0.35% | 0.31% | 0.25% | 0.23% | 0.25% | 0.29% | 0.29% | 0.32% | 0.32% | 0.49% |
Graham Net Nets |
(12.00) | (10.74) | (9.76) | (4.54) | (4.54) | (2.11) | (3.57) | (2.33) | (1.26) | (0.88) |
Graham Number |
0.00 | 0.00 | 12.85 | 0.00 | 27.58 | 60.75 | 44.57 | 64.45 | 209.66 | 153.11 |
Earnings Yield |
(12.53%) | (43.71%) | 6.36% | (5.86%) | 9.49% | 10.44% | 7.84% | 7.92% | 25.77% | 7.86% |
Free Cash Flow Yield |
(20.73%) | 30.65% | 24.68% | 14.32% | 68.38% | 10.43% | 6.13% | 21.00% | 9.12% | 14.12% |
Revenue per Share |
197.55 | 190.66 | 179.35 | 178.72 | 167.98 | 182.39 | 179.32 | 202.32 | 213.36 | 236.38 |
Operating CF per Share |
5.62 | 11.93 | 10.27 | 11.92 | 32.44 | 14.68 | 10.13 | 23.36 | 21.12 | 39.27 |
Capex per Share |
(8.81) | (7.03) | (6.04) | (6.48) | (5.14) | (6.16) | (7.13) | (7.39) | (9.61) | (11.20) |
Free Cash Flow per Share |
(3.19) | 4.90 | 4.23 | 5.45 | 27.30 | 8.52 | 3.00 | 15.97 | 11.52 | 28.06 |
Cash per Share |
7.21 | 6.07 | 4.03 | 2.53 | 23.29 | 22.13 | 8.02 | 12.08 | 31.15 | 31.98 |
Shareholders Equity per Share |
10.89 | 5.36 | 6.73 | 4.23 | 8.92 | 19.23 | 23.00 | 30.67 | 60.06 | 66.74 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.89 | 5.36 | 6.73 | 4.23 | 8.92 | 19.23 | 23.00 | 30.67 | 60.06 | 66.74 |
Free Cash Flow |
(317.00) | 493.00 | 432.00 | 563.00 | 2,867.00 | 910.00 | 321.00 | 1,623.00 | 1,116.00 | 2,530.00 |
Working Capital |
1,223.00 | 1,241.00 | 779.00 | 876.00 | 2,300.00 | 1,966.00 | 1,505.00 | 2,407.00 | 3,372.00 | 3,386.00 |
Capital Expenditures |
(875.00) | (707.00) | (617.00) | (670.00) | (540.00) | (658.00) | (762.00) | (751.00) | (931.00) | (1,010.00) |
Net Current Asset Value |
(18,362.00) | (17,273.00) | (17,086.00) | (17,847.00) | (19,022.00) | (18,450.00) | (18,716.00) | (18,028.00) | (15,434.00) | (15,811.00) |
EV/EBIT |
12.89 | 14.32 | 9.87 | 11.99 | 8.78 | 7.67 | 8.34 | 8.57 | 3.76 | 8.04 |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 |
Price to Operating Income |
1.23 | 1.45 | 1.07 | 2.56 | 2.11 | 3.04 | 2.24 | 3.08 | 2.05 | 5.11 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.11 | 0.13 | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Cash ROIC |
(1.86%) | 3.06% | 2.71% | 3.64% | 15.01% | 4.54% | 1.74% | 8.39% | 5.07% | 11.46% |
Accounts Receivable Turnover |
6.99 | 6.95 | 6.99 | 6.88 | 6.48 | 7.14 | 6.71 | 7.02 | 7.59 | 8.36 |
Accounts Payable Turnover |
9.19 | 9.87 | 9.77 | 9.75 | 9.46 | 9.74 | 8.64 | 8.75 | 9.21 | 9.41 |
Inventory Turnover |
39.22 | 40.19 | 39.18 | 38.23 | 33.63 | 32.46 | 30.71 | 31.22 | 32.89 | 35.98 |
Average Days of Payables |
38.96 | 34.70 | 37.86 | 37.38 | 38.65 | 38.87 | 45.30 | 40.35 | 37.94 | 39.76 |
Days of Inventory on Hand |
9.56 | 8.54 | 9.57 | 9.63 | 11.78 | 11.48 | 12.20 | 11.78 | 10.15 | 10.17 |
Average Receivables |
2,806.00 | 2,761.00 | 2,618.50 | 2,684.50 | 2,721.50 | 2,730.00 | 2,856.50 | 2,928.50 | 2,725.00 | 2,550.50 |
Average Payables |
1,354.50 | 1,252.00 | 1,191.00 | 1,205.50 | 1,205.50 | 1,253.50 | 1,402.00 | 1,456.00 | 1,351.00 | 1,327.00 |
Average Inventory |
317.50 | 307.50 | 297.00 | 307.50 | 339.00 | 376.00 | 394.50 | 408.00 | 378.50 | 347.00 |
Average Assets |
24,191.50 | 24,043.00 | 22,897.00 | 22,887.00 | 25,235.50 | 27,342.50 | 27,367.50 | 27,734.00 | 28,624.00 | 29,306.50 |
Average Common Equity |
1,020.00 | 810.50 | 613.00 | 562.00 | 687.00 | 1,495.50 | 2,256.50 | 2,788.00 | 4,468.50 | 5,918.50 |
Columns are period end dates